Here are five things to know about the company’s shares:
• There were 735,172 short interest shares as of August 15, which decreased from around 1.2 million shares on July 31.
• The daily trading volume is 375,115 shares with a days-to-cover ratio at two days.
• Around 2 percent of the shares are short sold.
• Zacks upgraded Symmetry shares from “neutral” to “outperform” on Aug. 21.
• Zacks has an $11 price target on the stock.
The company reported earnings on Aug. 4 with $101 million in second quarter revenue. Revenue was up 2.3 percent. The company divested OEM Solutions earlier this year and the move is expected to improve liquidity and enhance growth.
More articles on orthopedic devices:
Tyber Medical rolls out new headless cannulated trauma screw
NuVasive Spine Foundation raises $370k in single event for charitable efforts
Orchid Orthopedic Solutions receives $300k grant
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
